← All trials
NCT04757532
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 3, 2020
- Primary completion
- Mar 10, 2021
- Completion date
- Mar 10, 2021
- First posted
- Feb 17, 2021
- Last posted
- Apr 26, 2021
- Enrollment
- 9
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Institut Hospital del Mar d'Investigacions MèdiquesLead sponsor
- Institut Hospital del Mar d'Investigacions MèdiquesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.